---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-140616"
form_type: "8-K"
ticker: "CIM"
cik: "0001409493"
company_name: "CHIMERA INVESTMENT CORP"
filed_at: "2024-05-16T23:59:59+00:00"
generated_at: "2026-06-01T19:48:14.574374+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Chimera Investment prices $65M of 9.000% Senior Notes due 2029

## Summary
- Offering of $65M aggregate principal of 9.000% Senior Notes due 2029; underwriters have 30-day option for additional $9.75M.
- Notes sold via underwriting agreement with Morgan Stanley, RBC, UBS, Wells Fargo, KBW, and Piper Sandler.
- Offering expected to close on May 22, 2024, subject to customary closing conditions.
- Notes issued under existing shelf registration statement; prospectus supplement filed May 15, 2024.

## SEC filing metadata
- accession: 0001193125-24-140616
- form_type: 8-K
- ticker: CIM
- cik: 0001409493
- company_name: CHIMERA INVESTMENT CORP
- filed_at: 2024-05-16T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1409493/000119312524140616/0001193125-24-140616-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1409493/000119312524140616/d813580d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-140616
- JSON: https://secwatch.observer/filing/0001193125-24-140616.json
- Plain text: https://secwatch.observer/filing/0001193125-24-140616.txt

## Key facts
- Material Agreements
  CHIMERA INVESTMENT CORP entered into Underwriting Agreement with Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, UBS Securities LLC, Wells Fargo Securities, LLC, Keefe, Bruyette & Woods, Inc., and Piper Sandler & Co., as underwriters valued at $65 million aggregate principal amount of 9.000% Senior Notes due 2029 (effective 2024-05-15).
  - Action: entry
  - Agreement: underwriting
  - Counterparty: Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, UBS Securities LLC, Wells Fargo Securities, LLC, Keefe, Bruyette & Woods, Inc., and Piper Sandler & Co., as underwriters
  - Value: $65 million aggregate principal amount of 9.000% Senior Notes due 2029
  - Effective: 2024-05-15
  source text: On May 15, 2024, Chimera Investment Corporation (the “Company”) launched and priced a registered underwritten public offering of $65 million aggregate principal amount of 9.000% Senior Notes due 2029 (the “Notes”). Pursuant to the Underwriting Agreement (as defined below), the Company also granted the Underwriters (as defined below) a 30-day option to purchase up to an additional $9.75 million aggregate principal amount of the Notes to cover over-allotments, if any. The Notes were sold pursuant to the Company’s registration statement on Form S-3 (File No. 333-261462) (the “Registration Statement”) and a related prospectus, as supplemented by a prospectus supplement dated May 15, 2024, filed with the Securities Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the issuance and sale of the Notes, the Company entered into an underwriting agreement (the “Underwriting Agreement”), dated as of May 15, 2024, by
  evidence_url: https://www.sec.gov/Archives/edgar/data/1409493/000119312524140616/0001193125-24-140616-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.